Table of Contents Author Guidelines Submit a Manuscript
Journal of Aging Research
Volume 2011, Article ID 438978, 7 pages
http://dx.doi.org/10.4061/2011/438978
Review Article

Connecting Cerebral White Matter Lesions and Hypertensive Target Organ Damage

1Hypertension Unit, Department of Internal Medicine, Institute of Medicine and Dermatology, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain
2Geriatric Unit, Department of Internal Medicine, Institute of Medicine and Dermatology, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain

Received 4 March 2011; Accepted 2 June 2011

Academic Editor: Ana Verdelho

Copyright © 2011 Cristina Sierra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Mancia, G. De Backer, A. Dominiczak et al., “2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC),” Journal of Hypertension, vol. 25, no. 6, pp. 1105–1187, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. G. Mancia, S. Laurent, E. Agabiti-Rosei et al., “Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force documental,” Blood Pressure, vol. 27, pp. 2121–2158, 2009. View at Google Scholar
  3. L. B. Goldstein, C. D. Bushnell, R. J. Adams et al., “Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association,” Stroke, vol. 42, pp. 517–584, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. L. Pantoni, “Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges,” The Lancet Neurology, vol. 9, no. 7, pp. 689–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. L. H. Henskens, R. J. van Oostenbrugge, A. A. Kroon, P. A. Hofman, J. Lodder, and P. W. De Leeuw, “Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients,” Journal of Hypertension, vol. 27, no. 4, pp. 846–853, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. Di Carlo, “Human and economic burden of stroke,” Age and Ageing, vol. 38, no. 1, pp. 4–5, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. S. Debette and H. S. Markus, “The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis,” British Medical Journal, vol. 341, p. c3666, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. L. J. Launer, “Epidemiology of white matter lesions,” Topics in Magnetic Resonance Imaging, vol. 15, no. 6, pp. 365–367, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. B. van Harten, J. M. Oosterman, B. J. Potter Van Loon, P. Scheltens, and H. C. Weinstein, “Brain lesions on MRI in elderly patients with type 2 diabetes mellitus,” European Neurology, vol. 57, no. 2, pp. 70–74, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. L. Pantoni and J. H. Garcia, “The significance of cerebral white matter abnormalities 100 years after Binswanger's report: a review,” Stroke, vol. 26, no. 7, pp. 1293–1301, 1995. View at Google Scholar · View at Scopus
  11. A. L. Vlek, F. L. Visseren, L. J. Kappelle et al., “Blood pressure and white matter lesions in patients with vascular disease: the SMART-MR study,” Current Neurovascular Research, vol. 6, no. 3, pp. 155–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Liao, L. Cooper, J. Cai et al., “Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC study,” Stroke, vol. 27, no. 12, pp. 2262–2270, 1996. View at Google Scholar · View at Scopus
  13. C. Dufouil, J. Chalmers, O. Coskun et al., “Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke. The PROGRESS magnetic resonance imaging substudy,” Circulation, vol. 112, no. 11, pp. 1644–1650, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. O. Godin, C. Tzourio, P. Maillard, B. Mazoyer, and C. Dufouil, “Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the three-city (3C)-dijon magnetic resonance imaging study,” Circulation, vol. 123, pp. 266–273, 2011. View at Google Scholar
  15. S. Reshef, L. Fried, N. Beauchamp, D. Scharfstein, D. Reshef, and S. Goodman, “Diastolic blood pressure levels and ischemic stroke incidence in older adults with white matter lesions,” Journals of Gerontology A, vol. 66, pp. 74–81, 2011. View at Google Scholar
  16. M. Vuorinen, A. Solomon, S. Rovio et al., “Changes in vascular risk factors from midlife to late life and white matter lesions: a 20-year follow-up study,” Dementia and Geriatric Cognitive Disorders, vol. 31, pp. 119–125, 2011. View at Google Scholar
  17. T. den Heijer, L. J. Launer, N. D. Prins et al., “Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe,” Neurology, vol. 64, no. 2, pp. 263–267, 2005. View at Google Scholar · View at Scopus
  18. P. N. Casale, R. B. Devereux, M. Milner et al., “Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men,” Annals of Internal Medicine, vol. 105, pp. 173–178, 1986. View at Google Scholar
  19. M. J. Koren, R. B. Devereux, P. N. Casale, D. D. Savage, and J. H. Laragh, “Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension,” Annals of Internal Medicine, vol. 114, no. 5, pp. 345–352, 1991. View at Google Scholar · View at Scopus
  20. M. Bikkina, D. Levy, J. C. Evans et al., “Left ventricular mass and risk of stroke in an elderly cohort: the Framingham heart study,” Journal of the American Medical Association, vol. 272, no. 1, pp. 33–36, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Shigematsu, M. Hamada, T. Ohtsuka et al., “Left ventricular geometry as an independent predictor for extracardiac target organ damage in essential hypertension,” American Journal of Hypertension, vol. 11, no. 10 I, pp. 1171–1177, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Pontremoli, M. Ravera, G. P. Bezante et al., “Left ventricular geometry and function in patients with essential hypertension and microalbuminuria,” Journal of Hypertension, vol. 17, no. 7, pp. 993–1000, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Lindgren, A. Roijer, O. Rudling et al., “Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke: a population-based study,” Stroke, vol. 25, no. 5, pp. 929–934, 1994. View at Google Scholar · View at Scopus
  24. W. T. Longstreth, T. A. Manolio, A. Arnold et al., “Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The cardiovascular health study,” Stroke, vol. 27, pp. 1274–1282, 1996. View at Google Scholar
  25. R. Schmidt, M. Hayn, F. Fazekas, P. Kapeller, and H. Esterbauer, “Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants,” Stroke, vol. 27, no. 11, pp. 2043–2047, 1996. View at Google Scholar · View at Scopus
  26. K. Kohara, B. Zhao, Y. Jiang et al., “Relation of left ventricular hypertrophy and geometry to asymptomatic cerebrovascular damage in essential hypertension,” American Journal of Cardiology, vol. 83, no. 3, pp. 367–370, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Sierra, A. de la Sierra, J. C. Paré, E. Gómez-Angelats, and A. Coca, “Correlation between silent cerebral white matter lesions and left ventricular mass and geometry in essential hypertension,” American Journal of Hypertension, vol. 15, no. 6, pp. 507–512, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. E. R. Fox, H. A. Taylor Jr., E. J. Benjamin et al., “Left ventricular mass indexed to height and prevalent MRI cerebrovascular disease in an African American cohort: the atherosclerotic risk in communities study,” Stroke, vol. 36, no. 3, pp. 546–550, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. K. Shimada, A. Kawamoto, K. Matsubayashi, and T. Ozawa, “Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure,” Hypertension, vol. 16, no. 6, pp. 692–699, 1990. View at Google Scholar · View at Scopus
  30. E. J. Benjamin and D. Levy, “Why is left ventricular hypertrophy so predictive of morbidity and mortality?” American Journal of the Medical Sciences, vol. 317, no. 3, pp. 168–175, 1999. View at Google Scholar · View at Scopus
  31. F. Fazekas, P. Kapeller, R. Schmidt, H. Offenbacher, F. Payer, and G. Fazekas, “The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease,” Journal of the Neurological Sciences, vol. 142, no. 1-2, pp. 121–125, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. D. S. Knopman, T. H. Mosley, K. R. Bailey, C. R. Jack Jr., G. L. Schwartz, and S. T. Turner, “Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships,” Journal of the Neurological Sciences, vol. 271, no. 1-2, pp. 53–60, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. M. Wada, H. Nagasawa, C. Iseki et al., “Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly,” Journal of the Neurological Sciences, vol. 272, no. 1-2, pp. 36–42, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. D. E. Weiner, K. Bartolomei, T. Scott et al., “Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders,” American Journal of Kidney Diseases, vol. 53, no. 3, pp. 438–447, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. C. S. Thompson and A. M. Hakim, “Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis,” Stroke, vol. 40, no. 5, pp. e322–e330, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. M. G. Shlipak, L. F. Fried, C. Crump et al., “Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency,” Circulation, vol. 107, no. 1, pp. 87–92, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Hassan, B. J. Hunt, M. O'Sullivan et al., “Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis,” Brain, vol. 126, no. 2, pp. 424–432, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Sierra, A. Coca, E. L. Schiffrin et al., “Vascular mechanisms in the pathogenesis of stroke,” Current Hypertension Reports, vol. 13, no. 3, pp. 200–207, 2011. View at Google Scholar
  39. M. Khatri, C. B. Wright, T. L. Nickolas et al., “Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS),” Stroke, vol. 38, no. 12, pp. 3121–3126, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. M. A. Ikram, M. W. Vernooij, A. Hofman, W. J. Niessen, A. Van Der Lugt, and M. M. B. Breteler, “Kidney function is related to cerebral small vessel disease,” Stroke, vol. 39, no. 1, pp. 55–61, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. W. Takahashi, Y. Tsukamoto, S. Takizawa, S. Kawada, and S. Takagi, “Relationship between chronic kidney disease and white matter hyperintensities on magnetic resonance imaging,” Journal of Stroke and Cerebrovascular Diseases, 2010. In press.
  42. M. L. Baker, P. J. Hand, J. J. Wang, and T. Y. Wong, “Retinal signs and stroke: revisiting the link between eye and brain,” Stroke, vol. 39, no. 4, pp. 1371–1379, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. L. Mimoun, P. Massin, and G. Steg, “Retinal microvascularisation abnormalities and cardiovascular risk,” Archives of Cardiovascular Diseases, vol. 102, no. 5, pp. 449–456, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. R. Klein, A. R. Sharrett, B. E. Klein et al., “Are retinal arteriolar abnormalities related to atherosclerosis? The atherosclerosis risk in communities study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 6, pp. 1644–1650, 2000. View at Google Scholar · View at Scopus
  45. R. Schneider, M. Rademacher, and S. Wolf, “Lacunar infarcts and white matter attenuation: ophthalmologic and microcirculatory aspects of the pathophysiology,” Stroke, vol. 24, no. 12, pp. 1874–1879, 1993. View at Google Scholar · View at Scopus
  46. I. Goto, K. Kimoto, S. Katsuki, T. Mimatsu, and H. Ikui, “Pathological studies on the intracerebral and retinal arteries in cerebrovascular and noncerebrovascular diseases,” Stroke, vol. 6, no. 3, pp. 263–269, 1975. View at Google Scholar · View at Scopus
  47. L. D. Hubbard, R. J. Brothers, W. N. King et al., “Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the atherosclerosis risk in communities study,” Ophthalmology, vol. 106, no. 12, pp. 2269–2280, 1999. View at Google Scholar · View at Scopus
  48. T. Y. Wong, R. Klein, A. R. Sharrett et al., “ARIC investigators. Atheroslerosis risk in communities study. Cerebral white matter lesions, retinopathy, and incident clinical stroke,” Journal of the American Medical Association, vol. 288, pp. 67–74, 2002. View at Google Scholar
  49. N. Cheung, T. Mosley, A. Islam et al., “Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study,” Brain, vol. 133, no. 7, pp. 1987–1993, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. W. T. Longstreth, E. K. M. Larsen, R. Klein et al., “Associations between findings on cranial magnetic resonance imaging and retinal photography in the elderly: the cardiovascular health study,” American Journal of Epidemiology, vol. 165, no. 1, pp. 78–84, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. M. K. Ikram, F. J. De Jong, E. J. Van Dijk et al., “Retinal vessel diameters and cerebral small vessel disease: the rotterdam scan study,” Brain, vol. 129, no. 1, pp. 182–188, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. P. Prati, A. Tosetto, D. Vanuzzo et al., “Carotid intima media thickness and plaques can predict the occurrence of ischemic cerebrovascular events,” Stroke, vol. 39, no. 9, pp. 2470–2476, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. T. A. Manolio, G. L. Burke, D. H. O'Leary et al., “Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the cardiovascular health study. CHS collaborative research group,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, pp. 356–365, 1999. View at Google Scholar
  54. F. Pico, C. Dufouil, C. Levy et al., “Longitudinal study of carotid atherosclerosis and white matter hyperintensities: the EVA-MRI cohort,” Cerebrovascular Diseases, vol. 14, no. 2, pp. 109–115, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. F. E. de Leeuw, J. C. de Groot, M. L. Bots et al., “Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study,” Journal of Neurology, vol. 247, no. 4, pp. 291–296, 2000. View at Google Scholar · View at Scopus
  56. J. R. Romero, A. Beiser, S. Seshadri et al., “Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment,” Stroke, vol. 40, no. 5, pp. 1590–1596, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. S. D. Shenkin, M. E. Bastin, T. J. MacGillivray et al., “Carotid intima-media thickness and cerebrovascular disease in community-dwelling older people without stroke,” Stroke, vol. 41, no. 9, pp. 2083–2086, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. C. Sierra, A. de la Sierra, J. Mercader, E. Gómez-Angelats, A. Urbano-Márquez, and A. Coca, “Silent cerebral white matter lesions in middle-aged essential hypertensive patients,” Journal of Hypertension, vol. 20, no. 3, pp. 519–524, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. C. K. Kim, S. H. Lee, B. J. Kim, W. S. Ryu, and B. J. Kim, “Age-independent association of pulse pressure with cerebral white matter lesions in asymptomatic elderly individuals,” Journal of Hypertension, vol. 29, pp. 325–329, 2011. View at Google Scholar
  60. S. Laurent, S. Katsahian, C. Fassot et al., “Aortic stiffness is an independent predictor of fatal stroke in essential hypertension,” Stroke, vol. 34, no. 5, pp. 1203–1206, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. L. H. G. Henskens, A. A. Kroon, R. J. van Oostenbrugge et al., “Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients,” Hypertension, vol. 52, no. 6, pp. 1120–1126, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. I. Shrestha, T. Takahashi, E. Nomura et al., “Association between central systolic blood pressure, white matter lesions in cerebral MRI and carotid atherosclerosis,” Hypertension Research, vol. 32, no. 10, pp. 869–874, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. E. J. van Dijk, N. D. Prins, S. E. Vermeer et al., “C-reactive protein and cerebral small-vessel disease: the Rotterdam scan study,” Circulation, vol. 112, no. 6, pp. 900–905, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. M. Wada, H. Nagasawa, K. Kurita et al., “Cerebral small vessel disease and C-reactive protein: results of a cross-sectional study in community-based Japanese elderly,” Journal of the Neurological Sciences, vol. 264, no. 1-2, pp. 43–49, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. R. Schmidt, H. Schmidt, M. Pichler et al., “C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian stroke prevention study,” Stroke, vol. 37, no. 12, pp. 2910–2916, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. S. E. Vermeer, E. J. van Dijk, P. J. Koudstaal et al., “Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam scan study,” Annals of Neurology, vol. 51, no. 3, pp. 285–289, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. C. B. Wright, Y. Moon, M. C. Paik et al., “Inflammatory biomarkers of vascular risk as correlates of leukoariosis,” Stroke, vol. 40, no. 11, pp. 3466–3471, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. H. S. Markus, B. Hunt, K. Palmer, C. Enzinger, H. Schmidt, and R. Schmidt, “Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke prevention study,” Stroke, vol. 36, no. 7, pp. 1410–1414, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. F. E. de Leeuw, M. de Kleine, C. J. M. Frijns, R. Fijnheer, J. Van Gijn, and L. J. Kappelle, “Endothelial cell activation is associated with cerebral white matter lesions in patients with cerebrovascular disease,” Annals of the New York Academy of Sciences, vol. 977, pp. 306–314, 2002. View at Google Scholar · View at Scopus
  70. I. L. H. Knottnerus, J. W. P. Govers-Riemslag, K. Hamulyak et al., “Endothelial activation in lacunar stroke subtypes,” Stroke, vol. 41, no. 8, pp. 1617–1622, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. A. S. Greenstein, R. Paranthaman, A. Burns et al., “Cerebrovascular damage in late-life depression is associated with structural and functional abnormalities of subcutaneous small arteries,” Hypertension, vol. 56, no. 4, pp. 734–740, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. D. Rizzoni, C. De Ciuceis, E. Porteri et al., “Altered structure of small cerebral arteries in patients with essential hypertension,” Journal of Hypertension, vol. 27, no. 4, pp. 838–845, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. D. Rizzoni, E. Porteri, G. E. M. Boari et al., “Prognostic significance of small-artery structure in hypertension,” Circulation, vol. 108, no. 18, pp. 2230–2235, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus